Journal
|
EGFR (Epidermal growth factor receptor) • TP53 (Tumor protein P53) • PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) • SMARCB1 (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily B, Member 1)
|
TP53 mutation • EGFR mutation • PIK3CA mutation • TP53 wild-type • CDKN2A negative • EGFR mutation + PIK3CA mutation • SMARCB1 mutation • TP53 overexpression